HN2new | past | comments | ask | show | jobs | submitlogin
Genetic Targets, Financial Creativity: BridgeBio's Model for Drug Development (sciencedirect.com)
2 points by randycupertino 25 days ago | hide | past | favorite | 1 comment


Interesting look at BridgeBio's spoke and hub drug development model, using genetically validated targets, rNPV (risk-adjusted value) and PoTS (probability of success) to set go/no-go decisions.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: